Targeting PI3K in cancer: mechanisms and advances in clinical trials

J Yang, J Nie, X Ma, Y Wei, Y Peng, X Wei - Molecular cancer, 2019 - Springer
Abstract Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling is one of the most important intracellular pathways, which can be considered as a …

PI3K inhibitors in cancer: clinical implications and adverse effects

R Mishra, H Patel, S Alanazi, MK Kilroy… - International journal of …, 2021 - mdpi.com
The phospatidylinositol-3 kinase (PI3K) pathway is a crucial intracellular signaling pathway
which is mutated or amplified in a wide variety of cancers including breast, gastric, ovarian …

Regulation of breast cancer metastasis signaling by miRNAs

BJ Petri, CM Klinge - Cancer and metastasis reviews, 2020 - Springer
Despite the decline in death rate from breast cancer and recent advances in targeted
therapies and combinations for the treatment of metastatic disease, metastatic breast cancer …

Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer–A comprehensive review from chemotherapy to immunotherapy

PJ Kaboli, F Salimian, S Aghapour, S **ang… - Pharmacological …, 2020 - Elsevier
Breast cancer is the most frequently occurring cancer in women. Chemotherapy in
combination with immunotherapy has been used to treat breast cancer. Atezolizumab …

Immunomodulatory properties of PI3K/AKT/mTOR and MAPK/MEK/ERK inhibition augment response to immune checkpoint blockade in melanoma and triple-negative …

Z Zhang, A Richmond, C Yan - International journal of molecular sciences, 2022 - mdpi.com
Hyperactivation of PI3K/AKT/mTOR and MAPK/MEK/ERK signaling pathways is commonly
observed in many cancers, including triple-negative breast cancer (TNBC) and melanoma …

Targeting DNA double-strand break repair pathways to improve radiotherapy response

M Toulany - Genes, 2019 - mdpi.com
More than half of cancer patients receive radiotherapy as a part of their cancer treatment.
DNA double-strand breaks (DSBs) are considered as the most lethal form of DNA damage …

Skp2 in the ubiquitin‐proteasome system: a comprehensive review

MD Asmamaw, Y Liu, YC Zheng… - Medicinal Research …, 2020 - Wiley Online Library
The ubiquitin‐proteasome system (UPS) is a complex process that regulates protein stability
and activity by the sequential actions of E1, E2 and E3 enzymes to influence diverse aspects …

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma

M Pi, H Kuang, C Yue, Q Yang, A Wu, Y Li… - Drug Resistance …, 2022 - Elsevier
Cancer cell metabolism including aerobic glycolysis, amino acid and fatty acid metabolism,
has been extensively studied. Metabolic reprogramming is a major hallmark of cancer …

Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer

X Wang, W Jiang, Y Du, D Zhu, J Zhang, C Fang… - Drug Resistance …, 2022 - Elsevier
Dysregulation or aberrant signaling transduction contributes to tumorigenesis. Targeting
these abnormal signaling pathways becomes an effective anticancer strategy. However …

Mechanisms of resistance to PI3K inhibitors in cancer: adaptive responses, drug tolerance and cellular plasticity

SCE Wright, N Vasilevski, V Serra, J Rodon… - Cancers, 2021 - mdpi.com
Simple Summary The phosphoinositide-3-kinase (PI3K) pathway is the most frequently
activated pathway in human cancers. Consequently, a number of compounds targeting the …